[1]
T. U. Shah, R. Liddle, M. S. Branch, P. Jowell, J. Obando, and M. Poleski, “Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial”, JOP. J Pancreas (Online), vol. 13, no. 5, pp. 514–518, Sep. 2012.